US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Takeda Pharmaceutical Co Ltd

18.24

+0.06000.33%

Pre-market: 18.240.00000.00%07:38 EDT

Volume:2.23M

Turnover:40.65M

Market Cap:58.05B

PE:-57.28

High:18.26

Open:18.24

Low:18.11

Close:18.18

52wk High:18.90

52wk Low:12.99

Shares:3.18B

Float Shares:3.09B

Volume Ratio:0.84

T/O Rate:0.07%

Dividend:0.63

Dividend Rate:3.44%

EPS(TTM):-0.3184

EPS(LYR):-0.3042

ROE:-2.26%

ROA:2.69%

PB:1.22

PE(LYR):-59.95

Loading ...

Overview Company News Filings

Takeda Pharmaceutical Fiscal Q4 Core Earnings, Revenue Rise; Issues Fiscal 2026 Outlook

MT Newswires Live

Press Release: Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results

Takeda Pharmaceutical Co Ltd expected to post earnings of JPY117.96 a share - Earnings Preview

Immigration Uncovers Trading Scam in Batam, 210 Foreigners Nabbed

Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions

Takeda Advances Pediatric ENTYVIO Study, Supporting Long-Term Growth Potential

Earning Preview: Takeda Pharmaceutical Co Ltd revenue is expected to increase by 6.75% this quarter, and institutional views are constructive

Takeda Says Phase 2/3 Trial of TAK-881 Meets Endpoint in Primary Immunodeficiency Disease

MT Newswires Live

Protagonist Therapeutics Opts Out of Rusfertide US Profit-Sharing Arrangement With Takeda Pharmaceutical

MT Newswires Live

Takeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside

Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors

Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors

Takeda upgraded to Outperform from Market Perform at Bernstein

Denali Therapeutics Regains Full Rights to Dementia Drug Following Takeda Partnership Termination

MT Newswires Live

Denali Therapeutics regains full rights to DNL593

Analysts Are Bullish on Top Healthcare Stocks: Allogene Therapeutics (ALLO), Takeda Pharmaceutical Company (TAK)

Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says

MT Newswires Live

Takeda says Phase 3 zasocitinib pill clears plaque psoriasis skin in about 70% patients

Takeda announces new data from Phase 3 studies of TAK-279

Takeda proposes Julie Kim for board election; Christophe Weber retires as CEO on June 24, 2026 shareholder vote

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TAK/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":18.24,"timestamp":1787601600000,"preClose":18.18,"halted":0,"volume":2232970,"hourTrading":{"tag":"盘前","latestPrice":18.24,"preClose":18.24,"latestTime":"07:38 EDT","volume":504,"amount":9222.959088,"timestamp":1787657881696,"change":0,"changeRate":0,"amplitude":0.003289},"delay":0,"changeRate":0.00330033003300323,"floatShares":3092000000,"shares":3182533200,"eps":-0.31842,"marketStatus":"Pre-Mkt","change":0.06,"latestTime":"08-25 07:46:26 EDT","open":18.24,"high":18.26,"low":18.11,"amount":40648713.45766,"amplitude":0.008251,"askPrice":20.08,"askSize":100,"bidPrice":16.66,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.31842,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787664600000},"marketStatusCode":1,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":18.24,"dividendRate":0.03443,"preHourTrading":{"tag":"盘前","latestPrice":18.24,"preClose":18.24,"latestTime":"07:38 EDT","volume":504,"amount":9222.959088,"timestamp":1787657881696,"change":0,"changeRate":0,"amplitude":0.003289},"postHourTrading":{"tag":"盘后","latestPrice":18.4784,"preClose":18.24,"latestTime":"19:30 EDT","volume":1931,"amount":35246.6968,"timestamp":1787614206432,"change":0.2384,"changeRate":0.01307,"amplitude":0.01307},"volumeRatio":0.8401488012466387,"impliedVol":0.172,"impliedVolPercentile":0.076},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3092000000,"roa":"2.69%","roe":"-2.26%","lyrEps":-0.304241,"volumeRatio":0.8401488012466387,"shares":3182533200,"dividePrice":0.6278,"high":18.26,"amplitude":0.008251,"preClose":18.18,"low":18.11,"week52Low":12.99,"pbRate":"1.22","psRate":"2.00","week52High":18.895,"institutionHeld":0.1244,"latestPrice":18.24,"eps":-0.31842,"divideRate":0.034419,"volume":2232970,"delay":0,"ttmEps":-0.31842,"open":18.24,"prevYearClose":15.59,"prevWeekClose":18.18,"prevMonthClose":17.09,"prevQuarterClose":16.03,"fiveDayClose":17.38,"twentyDayClose":17.44,"sixtyDayClose":16.15},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"TAK","fiscalQuarterEnding":"2026/06","expectedEps":0.41,"name":null,"time":"","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"","actualEps":0.48},{"market":"US","date":"2026-05-13","symbol":"TAK","fiscalQuarterEnding":"2026/03","expectedEps":0.21,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778644800000,"reportTimeType":"pre","actualEps":0.28},{"market":"US","date":"2026-01-29","symbol":"TAK","fiscalQuarterEnding":"2025/12","expectedEps":0.55,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":0.48},{"date":"2025-10-30","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":0.44,"defaultRemindTime":1761811200000,"name":null,"time":"Pre-MKt","dateTimestamp":1761796800000,"actualEps":0.44},{"market":"US","date":"2025-07-30","symbol":"TAK","fiscalQuarterEnding":"2025/06","expectedEps":0.47,"name":null,"time":"","type":"earning","dateTimestamp":1753848000000,"reportTimeType":"","actualEps":0.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1689480000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2026-08-21","current":-57.282834,"percent":0.011218,"low":-61.265492,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"high":247.195474,"avg":39.99217,"sd":47.441771,"marketCap":57973616102.57},"quantilePoints":[{"date":"2021-08-27","current":13.304453,"twenty":25.07978,"median":36.81694,"eighty":90.040671,"marketCap":52184954198.97},{"date":"2021-09-03","current":13.585277,"twenty":24.895379,"median":36.800541,"eighty":89.938325,"marketCap":53414238064.1},{"date":"2021-09-10","current":13.6801,"twenty":24.732641,"median":36.787118,"eighty":89.91883,"marketCap":53684261064.92},{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41644103120.04},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42404430023},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41300590483.72},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39610552206.76},{"date":"2024-06-28","current":45.436656,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":40691773038.88},{"date":"2024-07-05","current":46.209907,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41429859502.63},{"date":"2024-07-12","current":47.281654,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43144411716.7},{"date":"2024-07-19","current":46.533596,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42599959119.02},{"date":"2024-07-26","current":46.698609,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":43774096625.98},{"date":"2024-08-02","current":44.272889,"twenty":15.841528,"median":31.485125,"eighty":84.95809,"marketCap":45300242074.37},{"date":"2024-08-09","current":43.014896,"twenty":15.841528,"median":31.485125,"eighty":84.034079,"marketCap":44025677518.59},{"date":"2024-08-16","current":45.710595,"twenty":15.841528,"median":31.485125,"eighty":83.611233,"marketCap":46246726032.37},{"date":"2024-08-23","current":46.418876,"twenty":15.841528,"median":31.485125,"eighty":83.285679,"marketCap":48080793858.92},{"date":"2024-08-30","current":45.805737,"twenty":15.841528,"median":31.485125,"eighty":82.840382,"marketCap":47110126928.06},{"date":"2024-09-06","current":45.150312,"twenty":15.841528,"median":31.485125,"eighty":82.567216,"marketCap":47633333133.33},{"date":"2024-09-13","current":43.733749,"twenty":15.841528,"median":31.485125,"eighty":82.35018,"marketCap":46692187320.02},{"date":"2024-09-20","current":45.192598,"twenty":15.841528,"median":31.485125,"eighty":81.917164,"marketCap":46914983400.73},{"date":"2024-09-27","current":44.008604,"twenty":15.841528,"median":31.485125,"eighty":81.717782,"marketCap":46173769906.47},{"date":"2024-10-04","current":44.8226,"twenty":15.841528,"median":31.485125,"eighty":81.193902,"marketCap":45207064894.75},{"date":"2024-10-11","current":45.034027,"twenty":15.841528,"median":31.485125,"eighty":80.903118,"marketCap":45273197191.14},{"date":"2024-10-18","current":45.203169,"twenty":15.841528,"median":31.485125,"eighty":80.121066,"marketCap":45314702691.87},{"date":"2024-10-25","current":43.395465,"twenty":15.841528,"median":31.485125,"eighty":79.259288,"marketCap":42802477236.79},{"date":"2024-11-01","current":23.34074,"twenty":15.841528,"median":31.394177,"eighty":76.252009,"marketCap":44255337707.7},{"date":"2024-11-08","current":23.061963,"twenty":15.841528,"median":31.223737,"eighty":52.659045,"marketCap":43818726338.15},{"date":"2024-11-15","current":23.302476,"twenty":15.841528,"median":30.720073,"eighty":52.113395,"marketCap":43649113935.95},{"date":"2024-11-22","current":22.482544,"twenty":15.841528,"median":30.492581,"eighty":51.914978,"marketCap":42094765685.01},{"date":"2024-11-29","current":22.318557,"twenty":15.841528,"median":30.428162,"eighty":51.719171,"marketCap":43004121919.03},{"date":"2024-12-06","current":22.537206,"twenty":15.841528,"median":30.363743,"eighty":51.54686,"marketCap":43593417925.5},{"date":"2024-12-13","current":22.602801,"twenty":15.841528,"median":30.265696,"eighty":51.06387,"marketCap":42654808427.14},{"date":"2024-12-20","current":22.438814,"twenty":15.841528,"median":30.156169,"eighty":50.729692,"marketCap":41620825476.96},{"date":"2024-12-27","current":22.89251,"twenty":15.841528,"median":30.11976,"eighty":50.270198,"marketCap":42157933916.75},{"date":"2025-01-03","current":22.854246,"twenty":15.841528,"median":30.084614,"eighty":49.695831,"marketCap":42120101324.52},{"date":"2025-01-10","current":22.526274,"twenty":15.834252,"median":30.039538,"eighty":48.706353,"marketCap":41387819255.78},{"date":"2025-01-17","current":22.072578,"twenty":15.834252,"median":29.98139,"eighty":47.742982,"marketCap":40954868347.09},{"date":"2025-01-24","current":22.056179,"twenty":15.834252,"median":29.928964,"eighty":47.376261,"marketCap":41086375616.12},{"date":"2025-01-31","current":32.066996,"twenty":15.834252,"median":29.8898,"eighty":47.184847,"marketCap":43068627249.87},{"date":"2025-02-07","current":31.518451,"twenty":15.834252,"median":29.8898,"eighty":46.698609,"marketCap":43370831342.3},{"date":"2025-02-14","current":31.625402,"twenty":15.834252,"median":29.8898,"eighty":46.623803,"marketCap":43271885610.15},{"date":"2025-02-21","current":32.135858,"twenty":15.834252,"median":29.8898,"eighty":46.463276,"marketCap":44737299221.36},{"date":"2025-02-28","current":33.019632,"twenty":15.834252,"median":29.8898,"eighty":46.1861,"marketCap":45710719655.87},{"date":"2025-03-07","current":33.965435,"twenty":15.826975,"median":29.881968,"eighty":45.994515,"marketCap":47968574450.17},{"date":"2025-03-14","current":32.579894,"twenty":15.826975,"median":29.881968,"eighty":45.856479,"marketCap":45709305301.84},{"date":"2025-03-21","current":33.462021,"twenty":15.826975,"median":29.881968,"eighty":45.756962,"marketCap":46697220950.86},{"date":"2025-03-28","current":32.837181,"twenty":15.826975,"median":29.881968,"eighty":45.646342,"marketCap":45537525126.69},{"date":"2025-04-04","current":32.910692,"twenty":15.826975,"median":29.881968,"eighty":45.486482,"marketCap":46959977925.4},{"date":"2025-04-11","current":28.911716,"twenty":15.834252,"median":29.864508,"eighty":45.423604,"marketCap":41903036554.51},{"date":"2025-04-17","current":30.516053,"twenty":15.834252,"median":29.864508,"eighty":45.37687,"marketCap":44665727413.14},{"date":"2025-04-25","current":31.299454,"twenty":15.826975,"median":29.853656,"eighty":45.205165,"marketCap":45236702475.67},{"date":"2025-05-02","current":32.353752,"twenty":15.826975,"median":29.853656,"eighty":45.143969,"marketCap":46627023849.03},{"date":"2025-05-09","current":62.186826,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46246122430},{"date":"2025-05-16","current":59.013194,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":43629573670.78},{"date":"2025-05-23","current":60.272181,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":45243750600.82},{"date":"2025-05-30","current":62.428377,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46713186360.41},{"date":"2025-06-06","current":62.153426,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":46690667816.43},{"date":"2025-06-13","current":62.934861,"twenty":15.826975,"median":29.853656,"eighty":45.099269,"marketCap":47259274399.65},{"date":"2025-06-20","current":62.052124,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45950911927.98},{"date":"2025-06-27","current":63.18087,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47191840400.65},{"date":"2025-07-03","current":64.005724,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47693415916.83},{"date":"2025-07-11","current":64.055104,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47209686047.66},{"date":"2025-07-18","current":63.513752,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46158538139.51},{"date":"2025-07-25","current":63.308916,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46555456308.17},{"date":"2025-08-01","current":48.106805,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43759985637.51},{"date":"2025-08-08","current":48.654381,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45191185373.67},{"date":"2025-08-15","current":50.297108,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46622420863.67},{"date":"2025-08-22","current":52.350517,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":48379407617.45},{"date":"2025-08-29","current":50.434002,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46969989485.26},{"date":"2025-09-05","current":52.179399,"twenty":15.818034,"median":29.83907,"eighty":45.065741,"marketCap":48057469940.35},{"date":"2025-09-12","current":51.255365,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47683369897.6},{"date":"2025-09-19","current":51.084248,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":47282912126.15},{"date":"2025-09-26","current":50.627935,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":46290416349.68},{"date":"2025-10-03","current":48.574526,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":45123442627.46},{"date":"2025-10-10","current":48.163844,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43057554125.18},{"date":"2025-10-17","current":47.810202,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43420086875.26},{"date":"2025-10-24","current":49.008023,"twenty":15.819699,"median":29.842804,"eighty":45.065741,"marketCap":43939898848.11},{"date":"2025-10-31","current":196.128812,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":42096877735.37},{"date":"2025-11-07","current":199.628241,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":43122516182.74},{"date":"2025-11-14","current":212.188582,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45471927947.27},{"date":"2025-11-21","current":211.902035,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":44500274886.11},{"date":"2025-11-28","current":215.197333,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45545101317.81},{"date":"2025-12-05","current":210.61257,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45011991214.34},{"date":"2025-12-12","current":212.427372,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":45254225772.44},{"date":"2025-12-19","current":219.877613,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":46788038894.3},{"date":"2025-12-26","current":232.581228,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":49307900125.5},{"date":"2026-01-02","current":230.9097,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":48729268900.59},{"date":"2026-01-09","current":242.610705,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51132650268.4},{"date":"2026-01-16","current":242.276399,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":50569808771.94},{"date":"2026-01-23","current":244.329994,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":51041613744.96},{"date":"2026-01-30","current":73.324517,"twenty":15.819699,"median":29.842804,"eighty":45.107651,"marketCap":54139767928.12},{"date":"2026-02-06","current":77.171186,"twenty":15.819699,"median":29.842804,"eighty":45.118598,"marketCap":55518181293.68},{"date":"2026-02-13","current":78.528012,"twenty":15.819699,"median":29.842804,"eighty":45.203169,"marketCap":58174278066.56},{"date":"2026-02-20","current":80.98988,"twenty":15.819699,"median":29.842804,"eighty":45.358128,"marketCap":59032990935.72},{"date":"2026-02-27","current":81.400335,"twenty":15.819699,"median":29.842804,"eighty":45.393454,"marketCap":58849002644.08},{"date":"2026-03-06","current":79.553824,"twenty":15.819699,"median":29.842804,"eighty":45.478025,"marketCap":56940998250.88},{"date":"2026-03-13","current":79.357982,"twenty":15.819699,"median":29.842804,"eighty":45.710595,"marketCap":56281429903.04},{"date":"2026-03-20","current":80.68691,"twenty":15.819699,"median":29.842804,"eighty":45.805737,"marketCap":57640580474.28},{"date":"2026-03-27","current":81.700474,"twenty":15.819699,"median":29.842804,"eighty":45.946205,"marketCap":57787054549.19},{"date":"2026-04-02","current":82.399965,"twenty":15.819699,"median":29.842804,"eighty":46.155453,"marketCap":58414619614.42},{"date":"2026-04-10","current":80.189575,"twenty":15.819699,"median":29.842804,"eighty":46.418876,"marketCap":56894786236.46},{"date":"2026-04-17","current":78.147063,"twenty":15.819699,"median":29.842804,"eighty":46.632604,"marketCap":55443526794.1},{"date":"2026-04-24","current":74.636784,"twenty":15.819699,"median":29.842804,"eighty":46.753613,"marketCap":52882297496.5},{"date":"2026-05-01","current":73.293741,"twenty":15.819699,"median":29.842804,"eighty":47.281654,"marketCap":52807070808.15},{"date":"2026-05-08","current":72.930001,"twenty":15.819699,"median":29.842804,"eighty":47.890056,"marketCap":52641729349.45},{"date":"2026-05-15","current":43.474739,"twenty":21.105555,"median":29.8898,"eighty":48.072582,"marketCap":52716863079.61},{"date":"2026-05-22","current":42.090665,"twenty":21.242858,"median":29.981195,"eighty":48.072582,"marketCap":50702234820.63},{"date":"2026-05-29","current":42.164812,"twenty":21.619498,"median":30.013965,"eighty":48.079427,"marketCap":50785809331.9},{"date":"2026-06-05","current":40.583014,"twenty":21.679053,"median":30.061417,"eighty":48.072582,"marketCap":48640465321.16},{"date":"2026-06-12","current":41.868225,"twenty":21.919152,"median":30.109117,"eighty":48.072582,"marketCap":50028878946.35},{"date":"2026-06-18","current":41.497491,"twenty":22.002933,"median":30.148932,"eighty":48.072582,"marketCap":49432180569.37},{"date":"2026-06-26","current":-52.738505,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":49718648879.09},{"date":"2026-07-02","current":-54.677192,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":51786280766.08},{"date":"2026-07-10","current":-55.558413,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":52145787737.79},{"date":"2026-07-17","current":-56.812857,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":53292981615.83},{"date":"2026-07-24","current":-59.180349,"twenty":22.014366,"median":30.152523,"eighty":48.079427,"marketCap":55033430509.43},{"date":"2026-07-31","current":-53.86164,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":55207403658.2},{"date":"2026-08-07","current":-54.125428,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":55841298206.35},{"date":"2026-08-14","current":-54.819093,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":56217337436.1},{"date":"2026-08-21","current":-56.313893,"twenty":22.026303,"median":30.156114,"eighty":48.086271,"marketCap":57973616102.57}],"updateTime":1787642078338},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635203042","title":"Takeda Pharmaceutical Fiscal Q4 Core Earnings, Revenue Rise; Issues Fiscal 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2635203042","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635203042?lang=en_us&edition=fundamental","pubTime":"2026-05-13 15:08","pubTimestamp":1778656131,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  reported fiscal Q4 core earnings Wednesday of 89 Japanese yen  per share, down from 49 yen a year earlier.Three analysts polled by FactSet expected 63.09 yen.Revenue for the quarter ended March 31 was 1.095 trillion yen, up from 1.052 trillion yen a year earlier.Analysts surveyed by FactSet expected 1.123 trillion yen.For fiscal 2026, the drugmaker expects core EPS of 472 yen and revenue of 4.640 trillion yen. Analysts polled by FactSet are expecting EPS of 497.59 yen and sales of 4.602 trillion yen for the year.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HEWJ","TAK","FXY","BK4007","YCL","YCS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635085182","title":"Press Release: Takeda Announces FY2025 Full Year Results and FY2026 Outlook, Highlighted by Excellent Pipeline Progress and Solid FY2025 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2635085182","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635085182?lang=en_us&edition=fundamental","pubTime":"2026-05-13 14:38","pubTimestamp":1778654280,"startTime":"0","endTime":"0","summary":"--  FY2025 Pipeline Successes Set the Stage for Pivotal Product Launches. --  Takeda is Entering a New Era & Transforming for Growth Acceleration. --  Revenue decreased by 1.7% YoY at actual exchange rates , resulting. from the loss of exclusivity for VYVANSE which was partially mitigated. by Growth and Launch Products. On a Core basis, Revenue decreased by 2.6%. \"In FY2025, despite topline headwinds, we delivered solid profit and cash flow through disciplined cost control, while directing growth investment toward new product launches and the pipeline. In FY2026, we will continue to focus on transforming operations and protecting profitability while delivering successful launches and advancing our pipeline. Strong cash flow generation and deleveraging will support long-term investment for growth acceleration and ensure competitive returns for our shareholders.\"","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4007","SG9999014039.USD","SG9999014013.SGD","BK4104","CEO","LU0109981661.USD","BK4572","SG9999014005.SGD","LU0211331839.USD","PRGS","AER","TAK","BK4232","LU1098665638.USD","LU2065732104.USD","SG9999014021.USD","R","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634477211","title":"Takeda Pharmaceutical Co Ltd  expected to post earnings of JPY117.96 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2634477211","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634477211?lang=en_us&edition=fundamental","pubTime":"2026-05-11 14:26","pubTimestamp":1778480765,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Co Ltd  expected to post earnings of JPY117.96 a share - Earnings Preview Takeda Pharmaceutical Co Ltd TAK.N, TAK is expected to  show a fall in quarterly revenue when it reports","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O0AD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634490790","title":"Immigration Uncovers Trading Scam in Batam, 210 Foreigners Nabbed","url":"https://stock-news.laohu8.com/highlight/detail?id=2634490790","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634490790?lang=en_us&edition=fundamental","pubTime":"2026-05-09 15:19","pubTimestamp":1778311198,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta - The Directorate General of Immigration has detained 210 foreign nationals suspected of involvement in a large-scale online investment fraud syndicate. Officials apprehended the gro","market":"nz","thumbnail":"https://statik.tempo.co/data/2026/04/20/id_1469691/1469691_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2026/04/20/id_1469691/1469691_720.jpg"],"rights":{"source":"tempo_highlight","url":"https://en.tempo.co/read/2102725/immigration-uncovers-trading-scam-in-batam-210-foreigners-nabbed","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/2102725/immigration-uncovers-trading-scam-in-batam-210-foreigners-nabbed","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633223271","title":"Takeda Advances TAK-279 Into Phase 2a Crohn’s Study, Signaling Long-Term GI Growth Ambitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2633223271","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633223271?lang=en_us&edition=fundamental","pubTime":"2026-05-08 00:31","pubTimestamp":1778171507,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is launching a Phase 2a trial called “An Ope...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-279-into-phase-2a-crohns-study-signaling-long-term-gi-growth-ambitions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-tak-279-into-phase-2a-crohns-study-signaling-long-term-gi-growth-ambitions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633122374","title":"Takeda Advances Pediatric ENTYVIO Study, Supporting Long-Term Growth Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2633122374","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633122374?lang=en_us&edition=fundamental","pubTime":"2026-05-08 00:31","pubTimestamp":1778171486,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda (TAK) is running a Phase 3 study called “An Open-L...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-advances-pediatric-entyvio-study-supporting-long-term-growth-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-advances-pediatric-entyvio-study-supporting-long-term-growth-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139870772","title":"Earning Preview: Takeda Pharmaceutical Co Ltd revenue is expected to increase by 6.75% this quarter, and institutional views are constructive","url":"https://stock-news.laohu8.com/highlight/detail?id=1139870772","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139870772?lang=en_us&edition=fundamental","pubTime":"2026-05-06 12:38","pubTimestamp":1778042295,"startTime":"0","endTime":"0","summary":"Abstract Takeda Pharmaceutical Co Ltd will report quarterly results on May 13, 2026 Pre-Market; this preview outlines consensus expectations for revenue, profit margins, and EPS, reviews the prior...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: Takeda Pharmaceutical Co Ltd revenue is expected to increase by 6.75% this quarter, and institutional views are constructive","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632956397","title":"Takeda Says Phase 2/3 Trial of TAK-881 Meets Endpoint in Primary Immunodeficiency Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2632956397","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632956397?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:21","pubTimestamp":1777900884,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical  said Monday that a pivotal phase 2/3 clinical trial of TAK-881-3001 in primary immunodeficiency disease met its primary endpoint of pharmacokinetic comparability with Hyqvia.TAK-881 showed comparable infection rates and immune protection to Takeda's Hyqvia, an established treatment, the company said.The drug also met its secondary endpoints with safety, efficacy, and tolerability profiles comparable to Hyqvia, the company said.TAK-881 is being evaluated for the potential to deliver the required immunoglobulin dose for PID patients in half the volume of Hyqvia, reducing infusion duration while keeping dosing flexible at every three or four weeks for PID patients, the company said.Takeda said it expects regulatory filings for TAK-881 in the US, European Union and Japan in fiscal 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630585661","title":"Protagonist Therapeutics Opts Out of Rusfertide US Profit-Sharing Arrangement With Takeda Pharmaceutical","url":"https://stock-news.laohu8.com/highlight/detail?id=2630585661","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630585661?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:25","pubTimestamp":1777386316,"startTime":"0","endTime":"0","summary":"Protagonist Therapeutics  exercised its right to opt out of the 50/50 US profit and loss sharing arrangement under its global license and collaboration agreement with Takeda Pharmaceutical  for rusfertide, Protagonist Therapeutics said Tuesday.As a result, Protagonist Therapeutics will be eligible to receive up to $400 million in opt-out payments.The company will also be entitled to a $75 million milestone payment upon rusfertide's approval in the US and up to $975 million in other milestone payments and tiered royalties on net sales, according to the statement.Takeda Pharmaceutical now holds exclusive development and commercialization rights to rusfertide in the US.Rusfertide is under FDA Priority Review in the US for the treatment of adult patients with polycythemia vera, Protagonist Therapeutics said.Price: 99.31, Change: +0.84, Percent Change: +0.85","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","PTGX","TAK","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629859053","title":"Takeda Targets Older Adults With New Dengue Vaccine Study, Eyeing Long-Term Market Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2629859053","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629859053?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:34","pubTimestamp":1776962083,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda Pharmaceutical Co. (TAK) is running a Phase 3 tria...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-targets-older-adults-with-new-dengue-vaccine-study-eyeing-long-term-market-upside?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-targets-older-adults-with-new-dengue-vaccine-study-eyeing-long-term-market-upside?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629859709","title":"Takeda’s TAK-505 Trial Marks a New Bet on Difficult Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2629859709","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629859709?lang=en_us&edition=fundamental","pubTime":"2026-04-24 00:33","pubTimestamp":1776962029,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda has launched a first-in-human trial called “A Phas...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takedas-tak-505-trial-marks-a-new-bet-on-difficult-solid-tumors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takedas-tak-505-trial-marks-a-new-bet-on-difficult-solid-tumors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628058217","title":"Takeda Extends Pediatric Entyvio Data: What Long-Term Safety Tracking Means for TAK Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2628058217","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628058217?lang=en_us&edition=fundamental","pubTime":"2026-04-17 00:31","pubTimestamp":1776357117,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda’s new update covers a phase 3b extension study cal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/takeda-extends-pediatric-entyvio-data-what-long-term-safety-tracking-means-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/takeda-extends-pediatric-entyvio-data-what-long-term-safety-tracking-means-for-tak-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ISBC","TAK","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625194735","title":"Takeda upgraded to Outperform from Market Perform at Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2625194735","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625194735?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:50","pubTimestamp":1775656205,"startTime":"0","endTime":"0","summary":"Bernstein upgraded Takeda (TAK) to Outperform from Market Perform with a price target of 6,900 yen, up from 5,100 yen, citing “bold” cost cuts and ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-upgraded-to-outperform-from-market-perform-at-bernstein-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-upgraded-to-outperform-from-market-perform-at-bernstein-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","FXY","YCL","HEWJ","YCS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625673846","title":"Denali Therapeutics Regains Full Rights to Dementia Drug Following Takeda Partnership Termination","url":"https://stock-news.laohu8.com/highlight/detail?id=2625673846","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625673846?lang=en_us&edition=fundamental","pubTime":"2026-04-06 17:28","pubTimestamp":1775467681,"startTime":"0","endTime":"0","summary":"Denali Therapeutics  said Friday it regained full control of its investigational frontotemporal dementia therapy after Takeda Pharmaceuticals  terminated their joint development agreement.Takeda ended the commercialization partnership for strategic reasons rather than any concerns regarding the medication's safety or effectiveness, the company said.Denali Therapeutics will continue advancing the Phase 1/2 study, which recently completed enrollment with 40 participants and is expected to generate biomarker results by the end of this year, it said.Preliminary data from healthy volunteers demonstrated that the treatment successfully increased targeted protein levels in the brain without producing any significant safety signals, Denali said.Shares of Denali Therapeutics were up 1.6%, and shares of Takeda were down 2% in Monday premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4539","LENZ","BK4535","BK4548","BK4007","DNLI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625260176","title":"Denali Therapeutics regains full rights to DNL593","url":"https://stock-news.laohu8.com/highlight/detail?id=2625260176","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625260176?lang=en_us&edition=fundamental","pubTime":"2026-04-06 09:15","pubTimestamp":1775438108,"startTime":"0","endTime":"0","summary":"Denali Therapeutics (DNLI) announced that it has received notification from Takeda (TAK) of its decision to terminate the collaboration agreement b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/denali-therapeutics-regains-full-rights-to-dnl593-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/denali-therapeutics-regains-full-rights-to-dnl593-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4548","BK4539","LENZ","BK4535","DNLI","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623016309","title":"Analysts Are Bullish on Top Healthcare Stocks: Allogene Therapeutics (ALLO), Takeda Pharmaceutical Company (TAK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2623016309","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623016309?lang=en_us&edition=fundamental","pubTime":"2026-03-31 16:00","pubTimestamp":1774944042,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Allogene Therapeutics (ALLO) and Takeda Pharmaceutic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-allogene-therapeutics-allo-takeda-pharmaceutical-company-tak-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-allogene-therapeutics-allo-takeda-pharmaceutical-company-tak-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4505","LABU","TAK","XBI","BLSX","BK4112","BK4137","BK4581","LU0128526141.USD","BK4007","LU0029874061.USD","ALLO","BLSG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623344939","title":"Alumis' Drug 'Very Positive' for Treatment of Psoriasis, Systemic Lupus Erythematosus, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2623344939","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623344939?lang=en_us&edition=fundamental","pubTime":"2026-03-30 23:25","pubTimestamp":1774884307,"startTime":"0","endTime":"0","summary":"Alumis' (ALMS) recent phase 3 results for its psoriasis treatment envudeucitinib is \"very positive\" for the company, Oppenheimer said in a note emailed Monday.Envudeucitinib had similar efficacy as Jo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0912757837.SGD","LU1778281490.HKD","LU0882574055.USD","BK4588","LU0345770308.USD","IE00BLSP4452.SGD","LU1221951129.SGD","JNJ","SG9999002224.SGD","IE00B4R5TH58.HKD","ALMS","LU1066053197.SGD","LU1989771016.USD","LU0114720955.EUR","BMY","LU1868837136.USD","IE00BBT3K403.USD","LU1280957306.USD","LU0289739699.SGD","LU0985481810.HKD","LU1244550577.SGD","LU0234570918.USD","LU0689626769.HKD","TAK","SG9999002232.USD","IE0034235303.USD","IE00BJT1NW94.SGD","LU2133065610.SGD","BK4504","LU0466842654.USD","LU1066051811.HKD","LU1221951046.USD","LU2471134796.USD","IE00B19Z3B42.SGD","BK4007","LU0267386448.USD","BK4532","BK4581","LU1883839398.USD","LU1059921491.USD","LU0070217475.USD","LU0203347892.USD","LU1732799900.SGD","LU0225771236.USD","OPY","LU2360032135.SGD","IE00BKVL7J92.USD","LU0889566641.SGD","LU0345769128.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623315937","title":"Takeda says Phase 3 zasocitinib pill clears plaque psoriasis skin in about 70% patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2623315937","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623315937?lang=en_us&edition=fundamental","pubTime":"2026-03-30 17:57","pubTimestamp":1774864634,"startTime":"0","endTime":"0","summary":"Takeda disclosed new Phase 3 data for investigational oral TYK2 inhibitor zasocitinib  in moderate-to-severe plaque psoriasis, already presented March 28 at 2026 American Academy of Dermatology Annual Meeting.Latitude PsO 3001 and 3002 showed about 70% of patients achieved sPGA 0/1 at week 16, versus about 11%–13% on placebo.Week 16 PASI 90 reached 61.3% in one study, 51.9% in other study, versus 5% or less on placebo.Latitude PsO 3002 showed PASI 75 at week 4 of 16.8%, versus 4.3% on placebo.Takeda targets New Drug Application submissions starting in fiscal 2026, with expected psoriasis launch timing shown as 2027 H1 pending regulatory review.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Takeda Pharmaceutical Co. Ltd. published the ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260330:nNDLH55cq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6523","LU2242646821.SGD","SG9999014492.USD","LU0877626530.USD","LU2242646235.USD","IE00BKZH1Z71.USD","TAK","LU0441851309.USD","SGXZ58947870.SGD","SG9999006266.SGD","LU2242652126.USD","BK6516","SG9999001846.SGD","SG9999014484.SGD","SG9999001135.SGD","SG9999000343.SGD","SG9999003826.SGD","LU0192582467.USD","LU0205439572.USD","BK6033","SGXZ27511609.SGD","SG9999004360.SGD","LU2401740654.USD","LU0326948709.USD","LU0898667661.SGD","LU1119993845.HKD","SG9999013478.USD","SG9999013486.USD","SG9999016042.SGD","LU1920063259.USD","LU1920062954.HKD","LU0188438112.USD","LU0532188223.SGD","LU0831103253.SGD","SG9999013460.SGD","LU1839390173.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623335170","title":"Takeda announces new data from Phase 3 studies of TAK-279","url":"https://stock-news.laohu8.com/highlight/detail?id=2623335170","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623335170?lang=en_us&edition=fundamental","pubTime":"2026-03-29 22:55","pubTimestamp":1774796108,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib, TAK-279, a next-generation, highly selective oral tyrosine kin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-announces-new-data-from-phase-3-studies-of-tak-279-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-announces-new-data-from-phase-3-studies-of-tak-279-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622553798","title":"Takeda proposes Julie Kim for board election; Christophe Weber retires as CEO on June 24, 2026 shareholder vote","url":"https://stock-news.laohu8.com/highlight/detail?id=2622553798","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622553798?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:58","pubTimestamp":1774519101,"startTime":"0","endTime":"0","summary":"Takeda shareholders will vote on a proxy proposal at the June 24, 2026 ordinary general meeting to elect director nominees and approve related board changes.The slate includes Julie Kim as a new internal director candidate, with a plan to appoint her as representative director, president and CEO after the meeting, and to have Christophe Weber retire the same day.Three new external director candidates are proposed for election: Bruce Broussard, Koichiro Kimura and Paul Stoffels.Six external directors are proposed to retire from the board: Jean Luc Butel, Ian Clark, Yoshiaki Fujimori, Koji Hatsukawa, Emiko Higashi and Michel Orsinger.The board decided to submit these candidates for shareholder approval at the meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, i","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL55Y1yf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999013486.USD","BK6033","LU0192582467.USD","SG9999013460.SGD","LU2401740654.USD","IE00BKZH1Z71.USD","SGXZ27511609.SGD","LU1119993845.HKD","SG9999013478.USD","LU0326948709.USD","TAK","LU0898667661.SGD","LU0188438112.USD","LU0532188223.SGD","LU2242646821.SGD","SG9999014484.SGD","SG9999014492.USD","BK6523","LU1920063259.USD","SG9999004360.SGD","LU1920062954.HKD","LU2242646235.USD","SG9999001135.SGD","SG9999003826.SGD","LU0831103253.SGD","SG9999006266.SGD","LU2242652126.USD","LU1839390173.USD","SG9999000343.SGD","LU0441851309.USD","SG9999016042.SGD","LU0877626530.USD","LU0205439572.USD","SGXZ58947870.SGD","BK6516","SG9999001846.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":91,"code":"91000000","status":"200"}]}}